Recently, we demonstrated the beneficial effects of engineered heart tissues for the treatment of dilated cardiomyopathy in rats. For further development of this technique we started to produce engineered tissue (ET) from mesenchymal stem cells. Interestingly, we observed a malignant tumor invading the heart with an inverse relationship between proliferation markers and connexin expression.
Identifer | oai:union.ndltd.org:DRESDEN/oai:qucosa:de:qucosa:80247 |
Date | 29 July 2022 |
Creators | Spath, Cathleen, Schlegel, Franziska, Leontyev, Sergey, Mohr, Friedrich-Wilhelm, Dhein, Stefan |
Publisher | Frontiers Media |
Source Sets | Hochschulschriftenserver (HSSS) der SLUB Dresden |
Language | English |
Detected Language | English |
Type | info:eu-repo/semantics/publishedVersion, doc-type:article, info:eu-repo/semantics/article, doc-type:Text |
Rights | info:eu-repo/semantics/openAccess |
Relation | 42 |
Page generated in 0.0019 seconds